Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The chromatin-remodeling protein ATRX is critical for neuronal survival during corticogenesis
Nathalie G. Bérubé, … , Ruth S. Slack, David J. Picketts
Nathalie G. Bérubé, … , Ruth S. Slack, David J. Picketts
Published February 1, 2005
Citation Information: J Clin Invest. 2005;115(2):258-267. https://doi.org/10.1172/JCI22329.
View: Text | PDF
Article Neuroscience

The chromatin-remodeling protein ATRX is critical for neuronal survival during corticogenesis

  • Text
  • PDF
Abstract

Mutations in genes encoding chromatin-remodeling proteins, such as the ATRX gene, underlie a number of genetic disorders including several X-linked mental retardation syndromes; however, the role of these proteins in normal CNS development is unknown. Here, we used a conditional gene-targeting approach to inactivate Atrx, specifically in the forebrain of mice. Loss of ATRX protein caused widespread hypocellularity in the neocortex and hippocampus and a pronounced reduction in forebrain size. Neuronal “birthdating” confirmed that fewer neurons reached the superficial cortical layers, despite normal progenitor cell proliferation. The loss of cortical mass resulted from a 12-fold increase in neuronal apoptosis during early stages of corticogenesis in the mutant animals. Moreover, cortical progenitors isolated from Atrx-null mice undergo enhanced apoptosis upon differentiation. Taken together, our results indicate that ATRX is a critical mediator of cell survival during early neuronal differentiation. Thus, increased neuronal loss may contribute to the severe mental retardation observed in human patients.

Authors

Nathalie G. Bérubé, Marie Mangelsdorf, Magdalena Jagla, Jackie Vanderluit, David Garrick, Richard J. Gibbons, Douglas R. Higgs, Ruth S. Slack, David J. Picketts

×

Figure 5

Options: View larger image (or click on image) Download as PowerPoint
AtrxNestinCre mice have a phenotype similar to that of AtrxFoxg1Cre
anim...
AtrxNestinCre mice have a phenotype similar to that of AtrxFoxg1Cre animals. (A and B) In situ whole-mount analysis of NestinCre-transgenic mice (E13.5) from line 2472 on a β-geo reporter strain background shows high Cre activity in the forebrain and spinal cord. AtrxloxP mice were mated to NestinCre-transgenic mouse line 2472 to achieve selective recombination of the Atrx gene in neuronal progenitors. ATRX (C) and DAPI (D) staining of forebrains isolated from AtrxNestinCre animals at birth demonstrate ATRX expression in early-born neurons of the marginal zone and the subplate, plus variegated expression throughout the cortex and hippocampus. Hematoxylin and eosin staining of cortex isolated from P0.5 mice of wild-type (E) and AtrxNestinCre animals (F) shows reduced cellularity. Similarly, neonatal hippocampal tissue sections from AtrxNestinCre (H) and a control littermate (G) also demonstrate hypocellularity in all hippocampal fields. Magnification, ×20 (C–H).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts